Valerio Therapeutics S.A.
ALVIO.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | €0 | €2 | €0 | €2 |
| % Growth | -92.6% | 1,814.6% | -95.1% | – |
| Cost of Goods Sold | €2 | €5 | €0 | €0 |
| Gross Profit | -€2 | -€3 | -€0 | €1 |
| % Margin | -1,482.5% | -168.8% | -83.1% | 82.6% |
| R&D Expenses | €0 | €1 | €0 | €3 |
| G&A Expenses | €0 | €0 | €0 | €0 |
| SG&A Expenses | €1 | €2 | €2 | €2 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | -€1 | €0 | €9 | €5 |
| Operating Expenses | €0 | €3 | €11 | €10 |
| Operating Income | -€2 | -€6 | -€11 | -€8 |
| % Margin | -1,710.3% | -346.7% | -12,275.3% | -441.2% |
| Other Income/Exp. Net | €1 | -€7 | -€1 | €0 |
| Pre-Tax Income | -€1 | -€13 | -€12 | -€8 |
| Tax Expense | -€0 | €0 | -€1 | €1 |
| Net Income | -€0 | -€13 | -€11 | -€9 |
| % Margin | -165.1% | -761.3% | -12,312.4% | -483.3% |
| EPS | -0.001 | -0.084 | -0.067 | -0.056 |
| % Growth | 98.3% | -26.2% | -18.4% | – |
| EPS Diluted | -0.001 | -0.084 | -0.067 | -0.056 |
| Weighted Avg Shares Out | 154 | 154 | 164 | 154 |
| Weighted Avg Shares Out Dil | 154 | 154 | 164 | 154 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €0 | €0 |
| Interest Expense | €0 | €0 | €0 | -€0 |
| Depreciation & Amortization | €0 | €2 | €1 | €0 |
| EBITDA | -€0 | -€3 | -€9 | -€7 |
| % Margin | -82.5% | -173.9% | -10,592.1% | -403.4% |